AlpVision is proud to announce the signature of a distribution contract for its authentication technology with the Japanese company ISID. Specialized in IT and consulting services, ISID perfectly matches AlpVisionâ€™s needs in terms of commercial and technical competences. Moreover, with 6 offices in Japan and 2600 employees, ISID has a strong presence in Japan. Japanese pharmaceutical companies represent about 20% of the worldwide pharmaceutical turnover and offer therefore interesting development perspectives for AlpVision. This collaboration complements our existing activities in Europe, USA and China. The Cryptoglyph technology is already deployed at large scale among the Fortune 200 pharmaceutical companies in the world and we are confident that Japanese companies will also adopt our solutions as their authentication requirements are similar to other countries.